Novo Nordisk Long Term Debt 2010-2025 | NVO

Novo Nordisk long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.

Novo Nordisk long term debt for the quarter ending March 31, 2025 was $13.589B, a 456.75% increase year-over-year.
Novo Nordisk long term debt for 2024 was $13.003B, a 336.24% increase from 2023.
Novo Nordisk long term debt for 2023 was $2.981B, a 13.44% decline from 2022.
Novo Nordisk long term debt for 2022 was $3.443B, a 66.99% increase from 2021.

Fatal error: Uncaught TypeError: number_format(): Argument #1 ($num) must be of type float, string given in /var/www/html/macrotrends/public_html/assets/php/new_chart_page_NEW.php:2765 Stack trace: #0 /var/www/html/macrotrends/public_html/assets/php/new_chart_page_NEW.php(2765): number_format() #1 /var/www/html/macrotrends/public_html/assets/php/url_router.php(168): include('...') #2 {main} thrown in /var/www/html/macrotrends/public_html/assets/php/new_chart_page_NEW.php on line 2765

Novo Nordisk Annual Long Term Debt (Millions of US $)
2024	$13,003
2023	$2,981
2022	$3,443
2021	$2,062
2020	$444
2019	$451
2018